Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Mounjaro

Megatrends Still Matter: 3 Growth Stocks for the Next 10 Years

Discover three megatrend stocks positioned for the next decade of growth as AI, healthcare innovation, and clean energy reshape the global economy

MarketBeat

Watchdog bans social media ads sharing discount codes for weight loss jabs

Social media posts were found to promote the drugs by using hashtags and encouraging followers to start their own weight-loss ‘journey’, alongside offering discounts

The Independent UK

Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All

As weight loss drugs move from injections to pills, this thematic ETF provides broad exposure for investors looking to profit from the industry’s next leg up.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Lorraine Kelly stunned as ITV star shows off four-stone weight loss after sharing Mounjaro journey

The ITV money expert said her body transformation has prompted her to overhaul both her wardrobe and her lifestyle

Evening Standard

Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk

Novo Nordisk’s (NYSE:NVO) nearly 11% pre-market drop on Monday and subsequent 9% dip at market open, in the aftermath of disappointing topline results from its evoke/evoke+ Alzheimer’s trials, is more than a pipeline setback. It’s a stress test for healthcare ETFs that have quietly become GLP-1 momentum vehicles. With two…

Benzinga

“She Lost Her Bass”: Meghan Trainor’s New Look Sparks Hilarious Fan Reactions

"I used science and support (shoutout to Mounjaro!) to help me after my 2nd pregnancy,” said the singer, who became famous for embracing her curves in 'All About That Bass.'

Bored Panda

Meghan Trainor looks unrecognisable at Baby2Baby Gala after revealing use of Mounjaro weight loss jabs

‘Where is Meghan Trainor and what did you do with her?’ joked shocked fans on social media

Evening Standard

Read news from The Economist, FT, and more,
with one subscription

'Who Is This?' Fans React to Meghan Trainor's Stunning Weight Loss Reveal at Baby2Baby Gala

Meghan Trainor stunned fans with her dramatic weight loss and glamorous look at the 2025 Baby2Baby Gala, revealing her fitness journey, lifestyle changes, and openness about using Mounjaro.

International Business Times UK

Eli Lilly Posts Stellar Q3: Long-Term Upside Is Well in Play

Eli Lilly just posted its fastest revenue growth ever, putting shares up 40% in less than three months. The stock continues to have strong long-term potential.

MarketBeat

Dad loses so much weight on Mounjaro that he needs a new passport

Airline staff didn’t recognise Mark Spurr in his old photo after he shed 13 stone

The Independent UK

Weight Loss Wars: Is Novo Nordisk’s Dominance Safe Against Eli Lilly?

As the battle for dominance heats up in the weight loss market, which stock is a better investment now?

Barchart

UK is ‘worst country in Europe’ for drug prices, says Mounjaro maker

Eli Lilly CEO says Britain’s strict regime means it could miss out on new drugs being rolled out unless it pays more

The Guardian - UK

NHS staffer now forced to work extra shifts to cover cost of Mounjaro

Carly Stokes, who has dropped 6st in a year using the weight-loss jab, will now have to pay £319 a month

The Independent UK

‘I lost more than 2 stone on Mounjaro - but my hair started to fall out’

Rhiannon Anne Griffiths-Bowen says the weight-loss benefits of taking Mounjaro outweighed the issue of hair loss

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

‘Gutted’: UK users of weight loss jab Mounjaro devastated by planned price hike

People using the jab reported positive results, but many say the increased cost will be prohibitively expensive, and they expect to put the weight back on when they stop

The Guardian - UK

Mounjaro users in UK warned against bulk buying before autumn price rise

Cost may increase as much as 170% from September, but patients warned against a quick switch to Wegovy

The Independent UK

Voices: Pricing people out of using Mounjaro would be bad news for the NHS

COMMENT: The astronomical rise in weight-loss drug prices caused by Trump’s tariffs could have a significant – and dangerous – impact on Britain’s pharmacies and patients, writes Leyla Hannbeck, CEO of the Independent Pharmacies Association

Euronews

Eli Lilly hikes UK price of blockbuster weight loss drug Mounjaro by up to 170%

The price hike is not expected to affect access for patients who receive Mounjaro through the National Health Service (NHS).

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Texas Sues Eli Lilly For Alleged Kickback Scheme Involving Mounjaro, Zepbound

Texas Attorney General Ken Paxton has filed a lawsuit against Eli Lilly and Co. (NYSE:LLY), accusing the pharmaceutical giant of bribing medical providers to promote its most profitable drugs, including the widely used GLP-1 medications Mounjaro and Zepbound for diabetes and weight loss.

Barchart

This Blue-Chip Stock Is Cooking Up a Major Growth Catalyst

Eli Lilly is poised for a major boost as new data shows its diabetes drug Mounjaro offers heart health benefits, potentially making it the top choice for patients with Type 2 diabetes.

Benzinga

Eli Lilly Obesity Drug Mounjaro Beats Legacy Trulicity On Cardio-Renal Health

Eli Lilly and Co. (NYSE:LLY) released topline results from SURPASS-CVOT, a head-to-head Phase 3 cardiovascular outcomes trial comparing Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, to Trulicity (dulaglutide), a GLP-1 receptor agonist.

The Independent UK

Weight-loss jab Mounjaro helps people shed much more weight than rival – study

Mounjaro (tirzepatide) and Wegovy (semaglutide) are weight-loss medicines that make people feel fuller for longer and therefore less hungry.

The Independent UK

Meghan Trainor reveals husband is also using Mounjaro after he gained some sympathy ‘pregnancy weight’

The ‘Dear Future Husband’ singer revealed she was taking Mounjaro earlier this month

The Independent UK

Diabetes and obesity drugs fuel Eli Lilly profit in the final quarter of 2024

Eli Lilly’s profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the drugmaker debuted a mostly better-than-expected 2025 forecast

Barchart

Elon Musk Weighs In on Weight-Loss Drug Stocks. Is LLY or NVO a Better Buy?

Elon Musk’s preference for Eli Lilly’s Mounjaro over Novo Nordisk’s Ozempic has sparked increased interest in weight-loss drug stocks.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.